Immunohistochemical Analysis of Cyclin A, Cyclin D1 and P53 in Mammary Tumors, Squamous Cell Carcinomas and Basal Cell Tumors of Dogs and Cats

Journal of Veterinary Medical Science

Volumn 62, Issue 7, 2000, Pages 743-750

  Murakami, Yuichi ^a   Tateyama, Susumu ^a   Rungsipipat, Anudep ^a   Uchida, Kazuyuki ^a   Yamaguchi, Ryoji ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Canine; Cyclin A; Cyclin D1; Feline; P53

Indexed keywords

CANIS FAMILIARIS; FELIDAE; FELIS CATUS;

CYCLIN A; CYCLIN D1; PROTEIN P53;

ANIMAL; ANIMAL DISEASE; ARTICLE; BASAL CELL CARCINOMA; CAT; CAT DISEASE; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; IMMUNOHISTOCHEMISTRY; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CAT DISEASES; CATS; CYCLIN A; CYCLIN D1; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; NEOPLASMS, BASAL CELL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034220868     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.62.743     Document Type: Article

References (48)

1. Alle, K. M., Henshall, S. M., Field, A. S. and Sutherland, R. L. 1998. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin. Cancer Res. 4: 847-854.
2. Aprikian, A. G., Sarkis, A. S., Fair, W. R., Zhang, Z., Fuks, Z. and Cordon-Cardo, C. 1994. Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J. Urol. 151: 1276-1280.
3. Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M. and Bartek, J. 1994. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer 57: 353-361.
4. Bartkova, J., Lukas, J., Muller, H., Strauss, M., Gusterson, B. and Bartek, J. 1995. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 55: 949-956.
5. Bukholm, I. K., Berner, J. M., Nesland, J. M. and Borresen-Dale, A. L. 1998. Expression of cyclin Ds in relation to p53 status in human breast carcinomas. Virchows Arch. 433: 223-228.
6. Cesarman, E., Inghirami, G., Chadburn, A. and Knowles, D. M. 1993. High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am. J. Pathol. 143: 845-856.
7. Chao, Y., Shih, Y. L., Chiu, J. H., Chau, G. Y., Lui, W. Y., Yang, W. K., Lee, S. D. and Huang, T. S. 1998. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res. 58: 985-990.
8. Courjal, F., Louason, G., Speiser, P., Katsaros, D., Zeillinger, R. and Theillet, C. 1996. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int. J. Cancer 69: 247-253.
9. Dobashi, Y., Shoji, M., Jiang, S. X., Kobayashi, M., Kawakubo, Y. and Kameya, T. 1998. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. Am. J. Pathol. 153: 963-972.
10. Esrig, D., Spruck, C. H., Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S. C., Skinner, D. G., Jones, P. A. and Cote, R. J. 1993. P53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am. J. Pathol. 143: 1389-1397.
11. Furihata, M., Ishikawa, T., Inoue, A., Yoshikawa, C., Sonobe, H., Ohtsuki, Y., Araki, K. and Ogoshi, S. 1996. Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin. Cancer Res. 2: 1781-1785.
12. Gamblin, R. M., Sagartz, J. E. and Couto, C. G. 1997. Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasm of dogs. Am. J. Vet. Res. 58: 857-863.
13. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D. and Peters, G. 1994. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54: 1812-1817.
14. Gimenez-Conti, I. B., Collet, A. M., Lanfranchi, H., Itoiz, M. E., Luna, M., Xu, H. J., Hu, S. X., Benedect, W. F. and Conti, C. J. 1996. P53, RB, and cyclin D1 expression in human oral verrucous carcinomas. Cancer 78: 17-23.
15. Hall, P. A. and Lane, D. P. 1994. P53 in tumour pathology: can we trust immunohistochemistry? - revisited! J. Pathol. 172: 1-4.
16. Huuhtanen, R. L., Blomqvist, C. P., Bohling, T. O., Wiklund, T. A., Tukiainen, E. J., Virolainen, M., Tribukait, B. and Andersson, L. C. 1999. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res. 59: 2885-2890.
17. Inoue, M. and Shiramizu, K. 1999. Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumors. J. Comp. Pathol. 120: 169-175.
18. Jiang, W., Kahn, S. M., Tomita, N., Zhang, Y. J., Lu, S. H. and Weinstein, I. B. 1992. Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res. 52: 2980-2983.
19. Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R. and Weinstein, I. B. 1993. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. U. S. A. 90: 9026-9030.
20. Kanai, M., Shiozawa, T., Xin, L., Nikaido, T. and Fujii, S. 1998. Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer 82: 1709-1719.
21. Keyomarsi, K. and Pardee, A. B. 1993. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 90: 1112-1116.
22. Kushner, J., Bradley, G., Young, B. and Jordan, R. C. 1999. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma. J. Oral Pathol. Med. 28: 77-81.
23. Mayr, B., Dressler, A., Reifinger, M. and Feil, C. 1998. Cytogenetic alterations in eight mammary tumors and tumor-suppressor gene p53 mutation in one mammary tumor from dogs. Am. J. Vet. Res. 59: 69-78.
24. McIntosh, G. G., Anderson, J. J., Milton, I., Steward, M., Parr, A. H., Thomas, M. D., Henry, J. A., Angus, B., Lennard, T. W. and Horne, C. H. 1995. Determination of the prognostic value of cyclin D1 overexpression in beast cancer. Oncogene 11: 885-891.
25. Mendoza, S., Konishi, T., Dernell, W. S., Withrow, S. J. and Miller, C. W. 1998. Status of the p53, RB and MDM2 genes in canine osteosarcoma. Aniticancer Res. 18: 4449-4453.
26. Michalides, R., van Veelen, N., Hart, A., Loftus, B., Wientjens, E. and Balm, A. 1995. Overexpression of cyclin D1 correlates with reccurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res. 55: 975-978.
27. Nogueira, C. P., Dolan, R. W., Gooey, J., Byahatti, S., Vaughan, C. W., Fuleihan, N. S., Grillone, G., Baker, E. and Domanowski, G. 1998. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope 108: 345-350.
28. Nylander, K., Stenling, R., Gustafsson, H., Zackrisson, B. and Roos, G. 1995. p53 expression and cell proliferation in squamous cell carcinomas of the head and neck. Cancer 75: 87-93.
29. Okuda, M., Umeda, A., Sakai, T., Ohashi, T., Momoi, Y., Youn, H. Y., Watari, T., Goitsuka, R., Tsujimoto, H. and Hasegawa, A. 1994. Cloning of feline p53 tumor-suppressor gene and its aberration in hematopoietic tumors. Int. J. Cancer 58: 602-607.
30. Oyama, T., Kashiwabara, K., Yoshimoto, K., Arnold, A. and Koerner, F. 1998. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res. 58: 2876-2880.
31. Piffko, J., Bankfalvi, A., Ofner, D., Joos, U., Bocker, W. and Schmid, K. W. 1995. Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval. J. Pathol. 176: 69-75.
32. Roncalli, M., Bosari, S., Marchetti, A., Buttitta, F., Bossi, P., Graziani, D., Peracchia, A., Bonavina, L., Viale, G. and Coggi, G. 1998. Cell cycle-related gene abnormalities and product expression in esophageal carcinoma. Lab. Invest. 78: 1049-1057.
33. Rubio, M. P., von Deimling, A., Yandell, D. W., Wiestler, O. D., Gusella, J. F. and Louis, D. N. 1993. Accumulation of wild type p53 protein in human astrocytomas. Cancer Res. 53: 3465-3467.
34. Rungsipipat, A., Tateyama, S., Yamaguchi, R., Uchida, K., Miyoshi, N. and Hayashi, T. 1999. Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. J. Vet. Med. Sci. 61: 27-32.
35. Said, T. K. and Medina, D. 1995. Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development. Carcinogenesis 16: 823-830.
36. Salicioni, A. M., Russo, I. H. and Russo, J. 1998. Correlation between cell cycle regulators and the immortalization and transformation of human breast epithelial cell lines. Int. J. Oncol. 13: 65-71.
37. Sheridan, E., Silcocks, P., Smith, J., Hancock, B. W. and Goyns, M. H. 1994. P53 mutation in a series of epithelial ovav rian cancers from the UK, and its prognostic significance. Eur. J. Cancer 30A: 1701-1704.
38. Shiozawa, T., Xin, L., Nikaido, T. and Fuji, S. 1997. Immunohistochemical detection of cyclin A with reference to p53 expression in endometrial endometrioid carcinomas. Int. J. Gynecol. Pathol. 16: 348-353.
39. Simpson, J. F., Quan, D. E., O'Malley, F., Odom-Maryon, T. and Clarke, P. E. 1997. Amplification of CCND1 and expression of its protein products, cyclin D1, in ductal carcinoma in situ of the breast. Am. J. Pathol. 151: 161-168.
40. Teifke, J. P. and Lohr, C. V. 1996. Immunohistochemical detection of p53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats, and dogs. J. Comp. Pathol. 114: 205-210.
41. Terada, T., Shimizu, K., Ryohei, I. and Nakanuma, Y. 1994. P53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections. Mod. Pathol. 7: 249-252.
42. van Leeuwen, I. S., Cornelisse, C. J., Misdorp, W., Goedegebuure, S. A., Kirpensteijn, J. and Rutteman, G. R. 1997. P53 gene mutations in osteosarcomas in the dog. Cancer Lett. 111: 173-178.
43. Veldhoen, N. and Milner, J. 1998. Isolation of canine p53 cDNA and detailed characterization of the full length canine p53 protein. Oncogene 16: 1077-1084.
44. Volm, M., Koomagi, R., Mattern, J. and Stammler, G. 1997. Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br. J. Cancer 75: 1774-1778.
45. Volm, M., Koomagi, R. and Rittgen, W. 1998. Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma. Int. J. Cancer 79: 294-299.
46. Volm, M., Rittgen, W. and Drings, P. 1998. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br. J. Cancer 77: 663-669.
47. Xu, L., Davidson, B. J., Murty, V. V., Li, R. G., Sacks, P. G., Garin-Chesa, P., Schantz, S. P. and Chaganti, R. S. 1994. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int. J. Cancer 59: 383-387.
48. Zhang, S. Y., Caamano, J., Cooper, F., Guo, X. and Klein-Szanto, A. J. 1994. Immunohistochemistry of cyclin D1 in human breast cancer. Am. J. Clin. Pathol. 102: 695-698.